AstraZeneca FluMist Supply Jumps With CDC's Seal Of Approval

US FDA's approval kept very limited amounts available the past two flu seasons; 2.7 million doses to be shipped for the 2018-2019 season.

flu season ahead against dark sky with white clouds

AstraZeneca PLC's FluMist Quadrivalent nasal spray flu vaccine will be widely available again as the company has shipped the first of 2.7 million doses for the 2018-2019 flu season.

The company announced the first shipments of FluMist in a Sept. 25 release. AstraZeneca was able to increase the supply...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership